National Cancer Institute of Kenya
- Company typePrivate
- Founded2012
- HeadquartersNairobi, Kenya
- Headcount51–100
- GTM typeB2C
- OfferingServices
National Cancer Institute of Kenya firmographics
Firmographics- Name
- National Cancer Institute of Kenya
- Legal name
- National Cancer Institute of Kenya
- Website
- https://ncikenya.go.ke
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
National Cancer Institute of Kenya industry classification
Industry- Product category
- Public Health and Cancer Care Services
- NAICS
- Administration of Public Health Programs (92312), Administration of Public Health Programs (923120), Voluntary Health Organizations (813212), Human Rights Organizations (813311)
- SIC
- Services-Health Services (8000), Services-Management Services (8741), Services-Educational Services (8200)
- akta.pro industry
- Government Public Health Grantmaking & Program OfficesHealthcare & Life Sciences/Public Health, Government & Regulators/Public Health Funding, Grants & Program AdministrationHealth Systems Performance & Quality Measurement (Public Sector)Healthcare & Life Sciences/Public Health, Government & Regulators/Health Program Evaluation & SurveillanceHospital-Integrated Cancer Centers (Acute Oncology Programs)
Keywords
Where National Cancer Institute of Kenya is headquartered
LocationHeadquarters
- HQ city
- Nairobi
- HQ country
- Kenya
- HQ region
- Africa
Offices1 record
Markets served
National Cancer Institute of Kenya business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
National Cancer Institute of Kenya product offering
Product offeringCore offering
National Cancer Institute of Kenya is a government parastatal that provides leadership, oversight, and coordination of cancer prevention, control, and care across Kenya. It delivers public cancer awareness campaigns, screening programs, research grants, and maintains the National Cancer Registry, while regulating cancer management centers through its Standards and Quality Assurance Directorate. Services are distributed free of charge to Kenyan citizens through online portals, regional offices, accredited cancer centers, and county health facilities.
Product overview
The National Cancer Institute of Kenya operates as a government-established regulatory and service body under the Cancer Prevention and Control Act (No. 15 of 2012). The organization offers a portfolio of interconnected digital portals and service programs: the NCI Kenya Portal and NaCaRe Portal provide online access to services and national cancer registry data; the Research Grants Program and specific research initiatives (Genomic Profiling, HPV Vaccination Impact Study) advance cancer research capacity; Cancer Screening Services and Awareness Campaigns deliver prevention and early detection services. The institute is organized into four technical directorates (Standards and Quality Assurance, Prevention and Control, Research and Data Informatics, Strategy and Resource Mobilization) that coordinate comprehensive cancer prevention, control, and care strategies nationwide.
Differentiator
Problem solved
Functional benefit
Products and services
- NCI Kenya Portal Online portal providing access to NCI-Kenya services, patient information, and cancer-related resources for the public and healthcare providers.
- NaCaRe Portal (National Cancer Registry) National Cancer Registry portal for cancer surveillance, data collection, and information management supporting policy formulation for cancer prevention and control.
- Research Grants Program Seed funding program for innovative cancer research projects aimed at advancing understanding of cancer causes, progression, and treatment in Kenya.
- Genomic Profiling of Kenyan Cancer Patients Research initiative analyzing genetic mutations specific to cancer patients in Kenya to develop targeted therapies effective for the local population.
- HPV Vaccination Impact Study Longitudinal study assessing HPV vaccination programs' impact on cervical cancer rates to support vaccination expansion and inform public health policies.
- Cancer Screening Services Comprehensive cancer screening programs including breast, cervical, prostate, and esophageal cancer screening across Kenya, conducting 50,000+ screenings annually.
- Cancer Awareness Campaigns Public education programs providing vital information about major cancer types, risk factors, and early detection importance, reaching over 1 million Kenyans.
Quantifiable outcome
- 1M+ Kenyans reached through awareness campaigns
- +3 more outcomes
Companies that use National Cancer Institute of Kenya
Customer profileSegments4 records
Ideal customer profiles4 records
National Cancer Institute of Kenya technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
National Cancer Institute of Kenya partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights4 records
National Cancer Institute of Kenya competitors and assessment
Company assessmentMarket position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
National Cancer Institute of Kenya social profiles
Digital presenceNational Cancer Institute of Kenya financial estimates
Financial estimateRevenue estimate
Valuation estimate
National Cancer Institute of Kenya leadership team
Management profileNumber of profiles
Profiles1 record
National Cancer Institute of Kenya funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
National Cancer Institute of Kenya M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about National Cancer Institute of Kenya
What does National Cancer Institute of Kenya do?
National Cancer Institute of Kenya is a government parastatal that provides leadership, oversight, and coordination of cancer prevention, control, and care across Kenya. It delivers public cancer awareness campaigns, screening programs, research grants, and maintains the National Cancer Registry, while regulating cancer management centers through its Standards and Quality Assurance Directorate. Services are distributed free of charge to Kenyan citizens through online portals, regional offices, accredited cancer centers, and county health facilities.
Is National Cancer Institute of Kenya a public or private company?
National Cancer Institute of Kenya is a private company. It is classified as state government owned and is currently operating.
When was National Cancer Institute of Kenya founded?
National Cancer Institute of Kenya was founded in 2012. It employs 51 to 100 people.
Where is National Cancer Institute of Kenya based?
National Cancer Institute of Kenya is headquartered in Nairobi, Kenya, in the Africa region.
Does National Cancer Institute of Kenya have an API?
No public API is recorded for National Cancer Institute of Kenya.
What industry is National Cancer Institute of Kenya in?
National Cancer Institute of Kenya's product category is Public Health and Cancer Care Services. Its primary akta.pro industry code is HLAJALAA, Government Public Health Grantmaking & Program Offices, with a secondary code of HLAJANAK, Health Systems Performance & Quality Measurement (Public Sector). Its NAICS code is 92312 and its SIC code is 8000.